As injectable GLP-1 medications become more widely used, many people wonder what happens when patients stop taking them outside of controlled clinical trials.
A new analysis from Cleveland Clinic, involving nearly 8,000 patients, suggests that…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply